Entero Therapeutics, Valuation
| ENTO Stock | 0.45 0.03 7.14% |
Entero Therapeutics, is undervalued. Entero Therapeutics, shows a prevailing Real Value of USD9.33 per share. The current price of the firm is USD0.45. Our model computes the value of Entero Therapeutics, from reviewing the firm fundamentals such as Current Valuation of 66.34 M, shares owned by insiders of 7.20 %, and Price To Book of 0.07 X as well as analyzing its technical indicators and probability of bankruptcy. Key fundamental drivers impacting Entero Therapeutics,'s valuation include:
Price Book 0.0684 | Enterprise Value 66.3 M | Enterprise Value Ebitda (0.10) |
Undervalued
Today
Please note that Entero Therapeutics,'s price fluctuation is risky at this time. Calculation of the real value of Entero Therapeutics, is based on 3 months time horizon. Increasing Entero Therapeutics,'s time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since Entero Therapeutics, is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Entero Stock. However, Entero Therapeutics,'s intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 0.45 | Real 9.33 | Target 36.0 | Hype 0.44 | Naive 0.4 |
The intrinsic value of Entero Therapeutics,'s stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Entero Therapeutics,'s stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Entero Therapeutics, helps investors to forecast how Entero stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Entero Therapeutics, more accurately as focusing exclusively on Entero Therapeutics,'s fundamentals will not take into account other important factors: Traditionally, analysts and sophisticated investors use multiple methods for valuing a cash-flow-generating entity or its stock. For example, some money managers use Entero Therapeutics,'s intrinsic value based on its ongoing forecasts of Entero Therapeutics,'s financial statements. In contrast, other private, professional wealth advisors use a multiplier approach by looking to relative value analysis against Entero Therapeutics,'s closest peers.
Entero Therapeutics, Cash |
|
Entero Valuation Drivers Correlation
Many accounts on the financial statements of Entero Therapeutics, are highly interrelated and sometimes correlated. Consequently, when conducting Entero's valuation analysis, one should examine all of the accounts reported to obtain a complete picture of its financial situation. We provide a unique feature to present a conventional correlation table purposely composed against different valuation-related drivers of Entero
Click cells to compare fundamentals
Entero Valuation Trend
Knowing Entero Therapeutics,'s actual value is paramount for traders when making sound investment determinations. Using both Entero Therapeutics,'s enterprise value as well as its market capitalization is the best way to estimate the value of the company and is usually enough for investors to make market timing decisions.
Entero Therapeutics, Total Value Analysis
Entero Therapeutics, is currently anticipated to have valuation of 66.34 M with market capitalization of 1.11 M, debt of 826.84 K, and cash on hands of . Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the Entero Therapeutics, fundamentals before making equity appraisal based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
66.34 M | 1.11 M | 826.84 K |
Entero Therapeutics, Asset Utilization
One of the ways to look at asset utilization of Entero is to check how much profit was generated for every dollar of assets it reports. Entero Therapeutics, shows a negative utilization of assets of -0.27 percent, losing USD0.002707 for each dollar of assets held by the firm. Inadequate asset utilization denotes the company is being less effective with each dollar of assets it shows. Put another way, asset utilization of Entero Therapeutics, shows how discouraging it operates for each dollar spent on its assets.Entero Therapeutics, Ownership Allocation
Entero Therapeutics, shows 7.2 percent of its outstanding shares held by insiders and 5.98 percent owned by other corporate entities.Entero Therapeutics, Profitability Analysis
Net Loss for the year was (15.79 M) with profit before overhead, payroll, taxes, and interest of 0.About Entero Therapeutics, Valuation
We use absolute and relative valuation methodologies to arrive at the intrinsic value of Entero Therapeutics,. In general, an absolute valuation paradigm, as applied to this company, attempts to find the value of Entero Therapeutics, based exclusively on its fundamental and basic technical indicators. By analyzing Entero Therapeutics,'s financials, quarterly and monthly indicators, and their related drivers, we attempt to find the most accurate representation of Entero Therapeutics,'s intrinsic value. As compared to an absolute model, our relative valuation model uses a comparative analysis of Entero Therapeutics,. We calculate exposure to Entero Therapeutics,'s market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Entero Therapeutics,'s related companies.| Last Reported | Projected for Next Year | ||
| Gross Profit | -29.3 K | -30.7 K |
Entero Therapeutics, Growth Indicators
Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines.
| Common Stock Shares Outstanding | 336.3 K |
Entero Therapeutics, Current Valuation Indicators
Entero Therapeutics,'s valuation analysis is a process of estimating the intrinsic value of all assets and outstanding equities. There are different methodologies and models we use to develop the final Entero Therapeutics,'s valuation. The techniques such as discounted cash flow and fundamental indicators such as book value per share or market capitalization are well known and widely used across most financial advisers and money managers.
Valuations are an essential part of business, for companies themselves, but also for investors. For companies, such as Entero Therapeutics,, valuations can help measure their progress and success and can help them track their performance in the market compared to others. In addition, investors can use Entero Therapeutics,'s valuations to help determine the worth of potential investments. They can do this by using data and information made public by a company. Regardless of who the valuation is for, it essentially describes Entero Therapeutics,'s worth.When determining whether Entero Therapeutics, offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Entero Therapeutics,'s financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Entero Therapeutics, Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Entero Therapeutics, Stock: Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Entero Therapeutics,. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate. To learn how to invest in Entero Stock, please use our How to Invest in Entero Therapeutics, guide.You can also try the Price Ceiling Movement module to calculate and plot Price Ceiling Movement for different equity instruments.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Entero Therapeutics,. If investors know Entero will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Entero Therapeutics, listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (11.04) | Return On Assets (0.27) | Return On Equity (0.15) |
The market value of Entero Therapeutics, is measured differently than its book value, which is the value of Entero that is recorded on the company's balance sheet. Investors also form their own opinion of Entero Therapeutics,'s value that differs from its market value or its book value, called intrinsic value, which is Entero Therapeutics,'s true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Entero Therapeutics,'s market value can be influenced by many factors that don't directly affect Entero Therapeutics,'s underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Entero Therapeutics,'s value and its price as these two are different measures arrived at by different means. Investors typically determine if Entero Therapeutics, is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Entero Therapeutics,'s price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.